评估与机械假体栓血栓瘤敏感性相关的遗传变异
Semih Kalkan1, M Ozan Gürsoy2, Ahmet Güner3
1Department of Cardiology, Basaksehir Cam Sakura City Hospital, Istanbul, Türkiye.
The American journal of cardiology
|October 25, 2024
概括
在因子II/原素 (G20210A),HPA-1 GPIIIa (T196C) 和MTHFR (A1298C) 的遗传变异可能会增加假血栓形成 (PVT) 的风险. 需要进一步的研究来证实这些关联,并指导临床实践.
科学领域:
- 心血管遗传学 心血管遗传学
- 血栓形成研究研究
- 人造心脏门是一种假心脏门.
背景情况:
- 假体血栓 (PVT) 是机械心脏的严重并发症.
- 遗传因素被怀疑是PVT发展的贡献者.
- 以前的研究还没有广泛探索与PVT相关的特定遗传变异.
研究的目的:
- 调查各种遗传多态化与PVT发生之间的关联.
- 识别可能成为PVT风险因素的特定遗传变异.
- 将PVT患者的遗传特征与没有血栓形成的对照组进行比较.
主要方法:
- 回顾性单中心研究设计.
- 对12种特定变异进行遗传基因型定型,包括II因子/原素 (G20210A),V因子莱登,MTHFR C677T,MTHFR A1298C和HPA-1 GPIIIa (T196C).
- 175名PVT患者和101名对照个体之间的遗传数据的比较.
主要成果:
- PVT组的年龄明显小于对照组 (p = 0.004).
- 在PVT患者中,异性因子II/原 (G20210A) (6.8%与1%,p=0.043) 和同性突变HPA-1 GPIIIa (T196C) (7.8%与0%,p=0.034) 的患病率较高.
- 异构性MTHFR (A1298C) 变异与阻塞性血栓形成 (46.9%与29.2%,p = 0.046) 的关联.
结论:
- 这项研究表明,特定的遗传变异 (HPA-1 GPIIIa,因子II/原,MTHFR A1298C) 与PVT风险之间存在潜在联系.
- 这些发现强调了遗传倾向在PVT中的作用.
- 需要对这些遗传因素进行进一步的广泛研究和临床考虑.
相关概念视频
01:22Mitral Valve Prolapse II: Assessment and Management
3
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
3
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
2
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
2
01:27Mitral Valve Prolapse I: Introduction
4
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
4
01:29Venous Thrombosis III: Interprofessional Care
2
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
2
01:22Mitral Stenosis I: Introduction
2
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
2